AU2020904571A0 - Preparation of mdma, different enantiomers, polymorphs, intermediates, formulations and their use - Google Patents

Preparation of mdma, different enantiomers, polymorphs, intermediates, formulations and their use

Info

Publication number
AU2020904571A0
AU2020904571A0 AU2020904571A AU2020904571A AU2020904571A0 AU 2020904571 A0 AU2020904571 A0 AU 2020904571A0 AU 2020904571 A AU2020904571 A AU 2020904571A AU 2020904571 A AU2020904571 A AU 2020904571A AU 2020904571 A0 AU2020904571 A0 AU 2020904571A0
Authority
AU
Australia
Prior art keywords
mdma
polymorphs
intermediates
formulations
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020904571A
Inventor
Victor Chiruta
Robert Desmond Renshaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotech Intellectual Holdings Ltd
Original Assignee
Biotech Intellectual Holdings Ltd
Filing date
Publication date
Application filed by Biotech Intellectual Holdings Ltd filed Critical Biotech Intellectual Holdings Ltd
Publication of AU2020904571A0 publication Critical patent/AU2020904571A0/en
Pending legal-status Critical Current

Links

AU2020904571A 2020-12-09 Preparation of mdma, different enantiomers, polymorphs, intermediates, formulations and their use Pending AU2020904571A0 (en)

Publications (1)

Publication Number Publication Date
AU2020904571A0 true AU2020904571A0 (en) 2021-01-07

Family

ID=

Similar Documents

Publication Publication Date Title
IL273883A (en) Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
EP4126879A4 (en) Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use
EP4010024A4 (en) Oral formulations of cannabis extracts and methods of making same
EP4108245A4 (en) New use of nucleotide
EP4169906A4 (en) Method for synthesis of roxadustat and intermediate thereof, and intermediate thereof
EP3989968A4 (en) Oral formulations of edaravone and method of manufacturing thereof
EP3914582A4 (en) Process for preparation of halogenated benzylamine and intermediates therof
EP3941394A4 (en) Soft tissue supports, and methods of making and using same
EP3915973A4 (en) Compound for preparation of antibody-payload conjugate and use thereof
AU2020904571A0 (en) Preparation of mdma, different enantiomers, polymorphs, intermediates, formulations and their use
EP3897684A4 (en) Cannabinoid formulations and methods of making same
EP4003310A4 (en) Softshell capsule formulations, and methods of preparation and use thereof
AU2021235467A1 (en) Process for the synthesis of cannabidiol and intermediates thereof
EP4005561A4 (en) Nano-micelle preparation of icaritin and preparation method therefor and application thereof
EP3972628A4 (en) Formulations of terlipressin
EP3920905A4 (en) Cannabinoid containing composition, methods of preparation and use thereof
AU2021900219A0 (en) Novel Method of Manufacture for MDMA, Different Intermediates, Enantiomers, Pharmaceutical Preparations, and Their Therapeutic Use
IL286713A (en) Liposomal formulations, and methods of using and preparing thereof
EP3911415A4 (en) Dapsone formulations and methods of using same
EP3864011A4 (en) Process for preparation of eribulin and intermediates thereof
EP3860985A4 (en) Process for the preparation of 2,2-difluoro-1,3-benzodioxole and intermediates thereof
EP3978476A4 (en) Solid form of aromatic compound and preparation method therefor
EP4077257A4 (en) Preparation of halogenated alkoxyethane
EP3877560A4 (en) Preparation of titanium dioxide
EP4014562A4 (en) Handover of group of devices